Detailed Information on Publication Record
2017
Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells
ONDRÁČEK, Jakub, Pavel FADRUS, Jiří ŠÁNA, Andrej BEŠŠE, Tomáš LOJA et. al.Basic information
Original name
Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells
Authors
ONDRÁČEK, Jakub (203 Czech Republic), Pavel FADRUS (203 Czech Republic, belonging to the institution), Jiří ŠÁNA (203 Czech Republic, belonging to the institution), Andrej BEŠŠE (703 Slovakia, belonging to the institution), Tomáš LOJA (703 Slovakia, belonging to the institution), Marek VEČEŘA (703 Slovakia, belonging to the institution), Lenka RADOVÁ (203 Czech Republic, belonging to the institution), Martin SMRČKA (203 Czech Republic, belonging to the institution), Pavel ŠLAMPA (203 Czech Republic, belonging to the institution) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution)
Edition
Anticancer Research, Athens, The International Institute of Anticancer Research, 2017, 0250-7005
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Greece
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.865
RIV identification code
RIV/00216224:14740/17:00095642
Organization unit
Central European Institute of Technology
UT WoS
000397129600019
Keywords in English
Glioblastoma; radioresistance; microRNA
Tags
Tags
International impact, Reviewed
Změněno: 28/3/2018 15:55, Mgr. Pavla Foltynová, Ph.D.
Abstract
V originále
Glioblastoma multiforme ( GBM) is the most aggressive intracranial tumor characterized with infaust prognosis. Despite advances in neurosurgical and radiotherapeutic techniques and chemotherapy, the median overall survival ranges between 12-15 months from diagnosis. The main cause of treatment failure is considered the presence of tumor cells resistant to conventional therapy, mainly radiotherapy. MicroRNAs (miRNAs) are small, non-coding RNAs that function as post-transcriptional regulators of gene expression and have been repeatedly proven to play important roles in pathogenesis and biological features of many cancers, including GBM and its radioresistant phenotype. In our study, we established radioresistant cells from the commonly used human GBM cell lines T98G, U87MG and U251. Consequently, we performed global miRNA expression profiling in both radioresistant and parental cell lines and identified 113 miRNAs with significantly different expression (p < 0.05) between these two groups (73 miRNAs were up-regulated, 40 miRNAs were down-regulated). Some of these miRNAs have been previously described in relation to ionizing radiation, and others were herein identified for the first time. We believe that after deeper functional investigation of identified miRNAs in relation to radioresistance, these miRNAs present potential predictive biomarkers or therapeutic targets in GBM.
Links
LQ1601, research and development project |
| ||
NV15-33158A, research and development project |
| ||
NV15-34553A, research and development project |
|